986 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Persium Advisors LLC

Persium Advisors LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 986 shares of the healthcare conglomerate’s stock, valued at approximately $499,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. M&T Bank Corp boosted its stake in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after buying an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. lifted its stake in shares of UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after purchasing an additional 41,308 shares during the last quarter. Parsifal Capital Management LP bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $21,165,000. Finally, Discipline Wealth Solutions LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $558,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Barclays raised their price target on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, TD Cowen lifted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $626.79.

Read Our Latest Report on UnitedHealth Group

UnitedHealth Group Stock Performance

Shares of UNH opened at $541.28 on Tuesday. The stock has a 50-day moving average of $554.92 and a two-hundred day moving average of $562.88. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market cap of $498.13 billion, a P/E ratio of 35.26, a P/E/G ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.56 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.